Skip to Content

Sonic Healthcare Ltd ADR SKHHY Stock Quote

| Rating as of

PINX:SKHHY

Morningstar‘s Stock Analysis SKHHY

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics SKHHY

Company Profile SKHHY

Business Description

Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the U.K., the second largest in Belgium and New Zealand and the third largest in the U.S. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second largest player in diagnostic imaging in Australia and the largest operator of medical centres in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the U.S. and 35% in Europe.

Contact
225 George Street, Level 22, Grosvenor Place
Sydney, NSW, 2000, Australia
T +61 298555444
Industry Diagnostics & Research
Most Recent Earnings
Fiscal Year End Jun 30, 2023
Employees 33,000